Search results
Healthier Together: Postpartum depression can put new moms, babies at risk
KIRO via Yahoo News· 4 hours ago“The anxiety and depression was something I’ve never felt before. I mean, I just cried, and cried,...
Can Esketamine Prevent Postpartum Depression?
Medscape· 7 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
A New Treatment Offers Hope to Mothers Battling Postpartum Depression
Denton Record-Chronicle· 3 days agoToday, the term for mothers having anxiety and depression after having a baby is called “postpartum ...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 1 day agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug ...
Why is a mother’s mental health so important? A doctor explains
Plus via Yahoo News· 1 day agoCNN: What kinds of treatments are available? Wen: Here is the good news. A variety of effective ...
An AI blood test purports to diagnose postpartum depression
Washington Post· 3 days agoPostpartum depression is a leading cause of maternal death, but its diagnosis and treatment is spotty at best, negligent at worst. Now ...
Reunion raises over $100M to build a better psychedelic drug
BioPharma Dive via Yahoo Finance· 15 hours agoThe funding will help Reunion pay for a mid-stage study testing its most advanced medicine —...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 11 hours agoReunion Neuroscience Inc., a clinical-stage biopharmaceutical company committed to pushing the boundaries of neuroscience, today announced the close of a $103 million Series A financing co-led ...
MPM BioImpact-owned Reunion raises $103M, one of the largest rounds for a psychedelic biotech
FierceBiotech· 11 hours agoIt’s taken decades for psychedelics to regain clinical and regulatory relevance. Reunion Neuroscience has cashed in on a $103 million series A, building on the promise of a phase 2-stage psychedelic ...
Perimenopause may raise risk of one mental health condition by 40%, study finds
CNN.com· 2 days agoIn the years leading up to menopause, a person can experience a multitude of symptoms, including...